This clinical trial studies the clinical effectiveness of S53P4 bioactive glass (BAG) as a bacterial growth inhibiting bone graft substitute in a one-stage or two-stage surgical procedure for treatment of chronic long bone osteomyelitis.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Eradication of infection In clinical presentation
Timeframe: 1-5 years follow-up
Absence of signs of chronic osteomyelitis on radiographic imaging (1/2)
Timeframe: 1 - 5 years follow-up
Absence of signs of chronic osteomyelitis on radiographic imaging (2/2)
Timeframe: 1 - 5 years follow-up
Eradication of infection in blood sample analysis (1/3)
Timeframe: 1 - 5 years follow-up
Eradication of infection in blood sample analysis (2/3)
Timeframe: 1 - 5 years follow-up
Eradication of infection in blood sample analysis (3/3)
Timeframe: 1 - 5 years follow-up